D-0162-2019 Class II Terminated

Recalled by Pharm D Solutions, LLC — Houston, TX

FDA drug recall D-0162-2019 was initiated by Pharm D Solutions, LLC on Sep 10, 2018 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Feb 5, 2021). Affected quantity: 2737 vials.

Recall details

Product Type
Drugs
Report Date
Nov 7, 2018
Initiation Date
Sep 10, 2018
Termination Date
Feb 5, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2737 vials

Product description

HCG 4000 Unit Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1704-01

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide

Code information

Lot: 03142018:73 Discard by: 3/9/2019; 04122018:64 Discard by: 4/7/2019; 07162018:84 Discard by: 7/11/2019; 06192018:36 Discard by: 6/12/2019; 08062018:28 Discard by: 8/1/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0162-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0162-2019. Report a data issue: hello@regdatalab.com.